Published in Int Immunopharmacol on March 06, 2014
The Iron age of host-microbe interactions. EMBO Rep (2015) 0.85
Bovine lactoferrin free of lipopolysaccharide can induce a proinflammatory response of macrophages. BMC Vet Res (2016) 0.78
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis (2005) 9.80
Single-step separation of red blood cells. Granulocytes and mononuclear leukocytes on discontinuous density gradients of Ficoll-Hypaque. J Immunol Methods (1974) 8.28
Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N Engl J Med (2003) 7.52
Immune evasion by staphylococci. Nat Rev Microbiol (2005) 7.22
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia. J Clin Microbiol (2004) 6.65
Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity (2009) 6.24
Emergence of community-associated methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of health care-associated blood stream infections. Clin Infect Dis (2006) 5.92
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis (2005) 4.52
Toxic shock syndrome and bacterial superantigens: an update. Annu Rev Microbiol (2001) 4.48
Geographic distribution of Staphylococcus aureus causing invasive infections in Europe: a molecular-epidemiological analysis. PLoS Med (2010) 4.05
Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus bacteremia. Antimicrob Agents Chemother (2007) 2.42
Mechanisms of mortality in early and late sepsis. Infect Immun (2006) 1.88
Modulating immunity as a therapy for bacterial infections. Nat Rev Microbiol (2012) 1.86
Endogenous gamma interferon, tumor necrosis factor, and interleukin-6 in Staphylococcus aureus infection in mice. Infect Immun (1995) 1.44
Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J Clin Invest (1987) 1.38
Impact of interferon-gamma receptor deficiency on experimental Staphylococcus aureus septicemia and arthritis. J Immunol (1995) 1.26
A system for production of commercial quantities of human lactoferrin: a broad spectrum natural antibiotic. Biotechnology (N Y) (1995) 1.21
Molecular pathogenesis of Staphylococcus aureus infection. Pediatr Res (2009) 1.13
Innate and adaptive immune responses against Staphylococcus aureus skin infections. Semin Immunopathol (2011) 1.12
Protective role of nitric oxide in Staphylococcus aureus infection in mice. Infect Immun (1998) 1.10
Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol (2011) 1.09
Staphylococcal superantigens: do they play a role in sepsis? Arch Immunol Ther Exp (Warsz) (2005) 1.07
The SaeR/S gene regulatory system induces a pro-inflammatory cytokine response during Staphylococcus aureus infection. PLoS One (2011) 1.05
Lactoferrin immunomodulation of DTH response in mice. Int Immunopharmacol (2002) 0.98
Lactoferrin decreases pollen antigen-induced allergic airway inflammation in a murine model of asthma. Immunology (2006) 0.98
Lactoferrin protects gut mucosal integrity during endotoxemia induced by lipopolysaccharide in mice. Inflammation (2000) 0.97
Differential effects of prophylactic, concurrent and therapeutic lactoferrin treatment on LPS-induced inflammatory responses in mice. Clin Exp Immunol (2002) 0.97
Clinical studies of lactoferrin in children. Biochem Cell Biol (2012) 0.96
Lactoferrin modulation of IL-12 and IL-10 response from activated murine leukocytes. Med Microbiol Immunol (2007) 0.91
Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells. Biochim Biophys Acta (1998) 0.91
Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages. Biochimie (2008) 0.90
Lactoferrin in health and disease. Postepy Hig Med Dosw (Online) (2007) 0.90
Use of Histopaque for isolating mononuclear cells from rabbit blood. J Immunol Methods (1987) 0.89
Gene delivery of SOCS3 protects mice from lethal endotoxic shock. Cell Mol Immunol (2005) 0.89
Protective effects of lactoferrin in Escherichia coli-induced bacteremia in mice: relationship to reduced serum TNF alpha level and increased turnover of neutrophils. Inflamm Res (2004) 0.88
Prevention of nosocomial infections in neonatal intensive care units. Am J Perinatol (2013) 0.88
Regulation of physiological and pathological Th1 and Th2 responses by lactoferrin. Biochem Cell Biol (2006) 0.88
Decline in invasive MRSA infection: where to go from here? JAMA (2010) 0.87
Lactoferrin modulation of BCG-infected dendritic cell functions. Int Immunol (2009) 0.86
Structure of the human lactoferrin gene and its chromosomal localization. Mol Cells (1998) 0.84
Gamma interferon treatment of patients with chronic granulomatous disease is associated with augmented production of nitric oxide by polymorphonuclear neutrophils. Clin Diagn Lab Immunol (1999) 0.84
The systemic inflammatory response syndrome (SIRS): immunology and potential immunotherapy. Infection (1994) 0.84
Influence of oral lactoferrin on Mycobacterium tuberculosis induced immunopathology. Tuberculosis (Edinb) (2011) 0.83
Surgical sepsis: dysregulation of immune function and therapeutic implications. Surgeon (2003) 0.83
Control of methicillin resistant Staphylococcus aureus infection utilizing a novel immunostimulatory peptide. Vaccine (2011) 0.83
Lactoferrin regulates the immune responses in post-surgical patients. Arch Immunol Ther Exp (Warsz) (2001) 0.82
Lactoferrin modulation of mycobacterial cord factor trehalose 6-6'-dimycolate induced granulomatous response. Transl Res (2010) 0.81
Oral lactoferrin treatment resolves amoebic intracecal infection in C3H/HeJ mice. Biochem Cell Biol (2012) 0.80
Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. Int Immunopharmacol (2004) 0.80
Bovine lactoferrin decreases histopathological changes in the liver and regulates cytokine production by splenocytes of obstructive jaundiced rats. Inflamm Res (2003) 0.79
Novel recombinant human lactoferrin: differential activation of oxidative stress related gene expression. J Biotechnol (2013) 0.79
Lactoferrin moderates LPS-induced hypotensive response and gut injury in rats. Int Immunopharmacol (2012) 0.78
Lactoferrin immunoprophylaxis for very preterm infants. Arch Dis Child Fetal Neonatal Ed (2012) 0.77
[Neonatal sepsis: new preventive strategies]. Minerva Pediatr (2013) 0.77
Homologous lactoferrin triggers mobilization of the myelocytic lineage of bone marrow in experimental mice. Stem Cells Dev (2013) 0.76